Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

January 2, 2021
Open Access

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients

Journal of Clinical Medicine
Michael DuerrFabian Halleck
January 8, 2021
Review
Open Access

Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review

Journal of Translational Medicine
Sija LandmanHans J P M Koenen
December 15, 2020
Review

Establishment of universal human embryonic stem cell lines

Immunology Letters
MingYue Kong, Di Zhou
December 29, 2020

The impact of depression on heart transplant outcomes: A Retrospective Single-Center Cohort Study

Clinical Transplantation
Angelo de la RosaMichelle M Kittleson
December 29, 2020
Review
Open Access

Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success

Frontiers in Immunology
Max J M SilvisGerardus P J van Hout
December 30, 2020

PATIENTS WITH POST TRANSPLANT BILIARY STRICTURES HAVE SIGNIFICANTLY HIGHER RATES OF LIVER TRANSPLANT FAILURE AND REJECTION: A NATIONWIDE INPATIENT ANALYSIS

Journal of Gastroenterology and Hepatology
Divyanshoo R KohliPrateek Sharma
December 22, 2020

T cell receptor repertoires within liver allografts are different to those in the peripheral blood

Journal of Hepatology
Young-Seon MederackeElmar Jaeckel
January 17, 2021
Open Access

Comprehensive Analysis of Cardiac Xeno-Graft Unveils Rejection Mechanisms

International Journal of Molecular Sciences
Min Young ParkIk Jin Yun
January 14, 2021
Open Access

The role of soluble programmed death protein-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1) in rat corneal transplantation rejection

Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
Guoguo YiHongwei Li
December 15, 2020
Case Report

Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant

Pediatric Transplantation
Wilson Y K ChanDaniel K L Cheuk
January 2, 2021
Review
Open Access

Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects

International Journal of Molecular Sciences
Piter J BosmaRonald Pj Oude-Elferink
December 22, 2020
Case Report
Open Access

Emphysematous gastritis due to Sarcina ventriculi infection in a diabetic liver-kidney transplant recipient

Autopsy & Case Reports
Rachel FanaroffCinthia B Drachenberg
January 5, 2021

Risk factors for delayed graft function and their impact on graft outcomes in live donor kidney transplantation

International Urology and Nephrology
Shivashankar DamodaranJorge Ortiz
January 1, 2021
Case Report
Open Access

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide

Case Reports in Transplantation
Iuliana VaxmanMorie A Gertz

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2021 Meta ULC. All rights reserved
/feed-previews/graft-rejection/cce2dbb5-a5f0-444e-b673-14ce44d8820e